リボミック Company Profile

We will create drugs for diseases that have no treatment using aptamers.

Our company is engaged in drug discovery business utilizing the drug discovery technology "RiboART System" to develop various new drugs that are not limited to specific diseases or target proteins. This drug discovery business consists of two components: in-house drug discovery and collaborative research with other pharmaceutical companies. For some drug candidates, we will conduct clinical trials in-house and, after obtaining Proof of Concept (POC), we will license them out to pharmaceutical companies.